Elephant Partners — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Gila Therapeutics is a clinical-stage biotech company developing a topical lingual signaling platform that delivers micro-dose PYY dissolving on the tongue to activate brain regions regulating food intake and metabolism.
BiotechDigital HealthHealthtechLongevityMinneapolis, US
Jon Freeman(Executive Officer)Donald R. Johns(Chief Medical Officer)Thomas J. Vasicek(Executive Officer, Director, Promoter)
BoardRichard Horan(Director)
Board seatChristopher De Souza· per SEC Form D · $10M raise · filed Dec 2023
Co-investorsArgonautic VenturesBroadview VenturesHarvard Business Angels of ChicagoiSelect Fund
Katalon provides a software test automation platform that supports web, mobile, desktop, and API testing with integrations and quick setup.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSAtlanta, US
Vu Lam(Founder)inJosh Lieberman(Director)Uy Tran(Founder)
Board seatJeremiah Daly· per SEC Form D
Co-investorsService Provider Capital
SecurEnds provides a unified platform combining identity governance, vendor risk management, cloud compliance, and access reviews to help organizations manage access, assess risk, and generate audit-ready evidence.
CybersecurityEnterprise SoftwareSaaSAtlanta, US
Tippu Sulthan Gagguturu(Executive Officer, Director, Promoter)Devender Reddy(Executive Officer)
BoardChristopher De Souza(Director)in
Board seatJeremiah Daly· per SEC Form D
Co-investors50 PartnersInfraVia Capital PartnersIsaiISAI Gestion
Didomi provides consent and preference management software that helps companies handle multi-regulation consent, privacy governance, and user privacy journeys across web, mobile, and CTV.
CybersecurityMarketing TechSaaS
Romain Gauthier(Founder)in
Co-investorsAdelieArrowroot CapitalMarlin Equity PartnersBreega
PVcase provides cloud-based and AutoCAD-based software for solar energy project development, including tools for site selection, utility-scale ground-mount and rooftop solar design, and energy yield modeling.
CleantechEnergySaaSSector AgnosticVilnius, LT
David Trainavicius(Founder)inDoug Geist(Co-founder & Chief Commercial Officer)inMelissa Nussbaum(CFO & COO)inDavid Trainavicius Douglas Geist(Founder)Douglas Geist(Founder)
Co-investorsContrarian VenturesEnergize CapitalHighland EuropePractica Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





















